Identification of endothelin receptors in normal and hyperplasic human prostate tissues

Specific endothelin‐1 (ET1) binding sites have been demonstrated in membranes derived from normal (NP) and benign hyperplasic (BPH) human prostate using an 125I‐ET1 binding assay. 125I saturation experiments and Scatchard analysis demonstrated the existence of a homogeneous population of binding sites with high affinity (Kdapp) and density (Bmax), respectively, 106 ± 15 pM and 1086 ± 399 fmol/mg protein for NP (n = 5) and 168 ± 26 pM and 964 ± 445 fmol/mg protein for BPH (n = 5). We demonstrated the presence of two subtypes of ET1 receptors, ETA and ETB, by means of the following ET1 competitors: ET2, ET3, and BQ123 (which is selective for the ETA receptor), and IRL1620 and sarafotoxine c (S6c) (which are selective for the ETB receptor). The displacement curves allowed us to conclude that the large majority (85%) of the ET1 receptors in normal and hyperplasic human prostate are of the A subtype. © 1996 Wiley‐Liss, Inc.

[1]  M. Polokoff,et al.  Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. , 1994, Pharmacological reviews.

[2]  H. Lepor,et al.  Localization of endothelin receptors in the human prostate. , 1994, The Journal of urology.

[3]  H. Lepor,et al.  Binding and functional properties of endothelin receptor subtypes in the human prostate. , 1994, Molecular pharmacology.

[4]  H. Lepor,et al.  Endothelin-1 in the human prostate: tissue levels, source of production and isometric tension studies. , 1993, The Journal of urology.

[5]  N. Brière,et al.  Growth regulatory properties of endothelins , 1993, Peptides.

[6]  Y. Urade,et al.  A reversible radioligand specific for the ETB receptor: [125I]Tyr13-Suc-[Glu9,Ala11,15]-endothelin-1(8- 21), [125I]IRL 1620. , 1992, Biochemical and biophysical research communications.

[7]  E. Liu,et al.  The endothelin receptor antagonist, BQ-123, inhibits angiotensin II-induced contractions in rabbit aorta. , 1992, Biochemical and biophysical research communications.

[8]  T. Sakurai,et al.  Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor , 1990, Nature.

[9]  S. Nakanishi,et al.  Cloning and expression of a cDNA encoding an endothelin receptor , 1990, Nature.

[10]  Sadao Kimura,et al.  A novel potent vasoconstrictor peptide produced by vascular endothelial cells , 1988, Nature.

[11]  H. Lepor,et al.  Contractile properties of human prostate adenomas and the development of infravesical obstruction , 1989, The Prostate.